Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 19, 2025 11:33 ET | Source: Block & Leviton LLP

BREAKING: Supernus Pharmaceuticals, Inc. Shares Down 14%; Investors Should Contact Block & Leviton to Find Out How They Might Recover Money Through The Firm’s Investigation

Block & Leviton is investigating Supernus Pharmaceuticals (SUPN) for potential securities fraud. SUPN investors with losses should contact the firm.